Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,561 | 280 | 99.0% |
| Education | $45.18 | 11 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,368 | 83 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $732.18 | 47 | $0 (2023) |
| Janssen Biotech, Inc. | $509.58 | 32 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $307.65 | 20 | $0 (2023) |
| Valeant Pharmaceuticals North America LLC | $284.19 | 16 | $0 (2017) |
| Allergan Inc. | $216.57 | 27 | $0 (2019) |
| PFIZER INC. | $182.43 | 8 | $0 (2019) |
| Celgene Corporation | $144.75 | 9 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $141.06 | 9 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $123.51 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $14.84 | 1 | ABBVIE INC. ($14.84) |
| 2023 | $830.18 | 40 | ABBVIE INC. ($341.69) |
| 2022 | $654.89 | 33 | ABBVIE INC. ($204.69) |
| 2021 | $512.91 | 33 | Takeda Pharmaceuticals U.S.A., Inc. ($157.67) |
| 2020 | $293.59 | 20 | Janssen Biotech, Inc. ($92.17) |
| 2019 | $461.41 | 37 | Takeda Pharmaceuticals U.S.A., Inc. ($129.42) |
| 2018 | $928.98 | 57 | AbbVie, Inc. ($280.77) |
| 2017 | $909.82 | 70 | Valeant Pharmaceuticals North America LLC ($284.19) |
All Payment Transactions
291 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/22/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $13.33 | General |
| 12/07/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.62 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Gastroenterology | ||||||
| 11/01/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Immunology | ||||||
| 10/31/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $12.48 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/30/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $96.87 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/10/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $25.44 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/29/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: IMMUNOLOGY | ||||||
| 09/26/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/19/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: IMMUNOLOGY | ||||||
| 09/12/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/08/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: VIROLOGY | ||||||
| 08/30/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Gastroenterology | ||||||
| 08/28/2023 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: IMMUNOLOGY | ||||||
| 08/23/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/04/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: VIROLOGY | ||||||
| 07/25/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.17 | General |
| Category: Neuroscience | ||||||
| 07/17/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.12 | General |
| Category: Neuroscience | ||||||
| 07/13/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.66 | General |
| Category: IMMUNOLOGY | ||||||
| 06/06/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: IMMUNOLOGY | ||||||
| 05/31/2023 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: VIROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 386 | 421 | $161,340 | $43,892 |
| 2022 | 9 | 328 | 356 | $127,268 | $37,314 |
| 2021 | 10 | 475 | 508 | $196,560 | $51,940 |
| 2020 | 14 | 539 | 597 | $209,362 | $57,908 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 80 | 82 | $45,100 | $16,236 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 102 | 126 | $13,860 | $7,805 | 56.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 73 | 80 | $52,000 | $5,870 | 11.3% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 22 | 22 | $5,390 | $3,870 | 71.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 42 | 43 | $17,630 | $2,849 | 16.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 20 | 20 | $12,600 | $2,814 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 18 | $2,880 | $1,664 | 57.8% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 15 | 15 | $4,680 | $1,637 | 35.0% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $7,200 | $1,147 | 15.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 49 | 50 | $27,500 | $9,880 | 35.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 128 | $13,276 | $8,263 | 62.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 61 | 63 | $40,950 | $5,165 | 12.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 37 | 38 | $15,580 | $3,565 | 22.9% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 22 | 23 | $14,490 | $3,151 | 21.7% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 16 | 16 | $3,920 | $2,856 | 72.9% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 11 | 11 | $2,827 | $1,974 | 69.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 14 | 14 | $6,720 | $1,280 | 19.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 13 | $2,005 | $1,181 | 58.9% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 71 | 72 | $39,600 | $14,481 | 36.6% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 112 | 123 | $79,950 | $11,027 | 13.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 112 | 129 | $12,642 | $8,324 | 65.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 49 | 49 | $20,090 | $4,825 | 24.0% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 26 | 26 | $16,380 | $3,827 | 23.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 39 | 39 | $5,655 | $2,874 | 50.8% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 30 | 30 | $14,400 | $2,671 | 18.5% |
About Dr. Medley Larkin, D.O
Dr. Medley Larkin, D.O is a Surgery healthcare provider based in Saginaw, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1992782569.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Medley Larkin, D.O has received a total of $4,607 in payments from pharmaceutical and medical device companies, with $14.84 received in 2024. These payments were reported across 291 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($4,561).
As a Medicare-enrolled provider, Larkin has provided services to 1,728 Medicare beneficiaries, totaling 1,882 services with total Medicare billing of $191,054. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Other Specialties Gastroenterology
- Location Saginaw, MI
- Active Since 12/27/2005
- Last Updated 02/23/2023
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1992782569
Products in Payments
- STELARA (Biological) $399.31
- ENTYVIO (Biological) $399.08
- RINVOQ (Biological) $330.22
- XIFAXAN (Drug) $312.56
- Humira (Biological) $305.68
- ZEPOSIA (Drug) $248.77
- Entyvio (Biological) $198.53
- HUMIRA (Biological) $197.03
- APRISO (Drug) $185.45
- LINZESS (Drug) $169.17
- VIBERZI (Drug) $114.26
- REMICADE (Biological) $110.27
- Lenvima (Drug) $109.89
- MOTEGRITY (Drug) $100.57
- MAVYRET (Drug) $89.56
- Cimzia (Drug) $81.80
- Mavyret (Drug) $79.29
- OCA (Drug) $78.40
- Creon (Drug) $65.95
- XELJANZ (Drug) $65.91
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Saginaw
Dr. Anthony Senagore, M.d, M.D
Surgery — Payments: $206,127
Maher Ghanem, Md, MD
Surgery — Payments: $110,437
Dr. Ryan Kim, M.d, M.D
Surgery — Payments: $46,387
Mr. Jonathan Murdock, Do, DO
Surgery — Payments: $29,345
Bakri Kaakeh, Md, MD
Surgery — Payments: $25,214
Dr. Vasanth Stalin, M.d, M.D
Surgery — Payments: $23,272